YahooOctober 22, 2026 at 4:45 PM NY4 Days Ago
MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes
Investors were awaiting full data from the late-stage trial of intismeran autogene plus Merck’s Keytruda at the European Society for Medical Oncology Congress on October 24.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
